<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02651792</url>
  </required_header>
  <id_info>
    <org_study_id>ketfol versus pethidine</org_study_id>
    <nct_id>NCT02651792</nct_id>
  </id_info>
  <brief_title>Ketamine- Propofol Versus Pethidine- Propofol in ERCP</brief_title>
  <official_title>Ketamine-propofol Versus Pethidine-propofol for Sedating Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <brief_summary>
    <textblock>
      The investigators aim to investigate the differences between ketamine propofol and pethidine
      propofol during ERCP in respect to endoscopist satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to investigate the differences between ketamine propofol and pethidine
      propofol during ERCP in respect to endoscopist satisfaction, amount of propofol consumption
      Any desaturation or apnea will be recorded when the oxygen saturation (SpO2) dropped to &lt;90%
      , time for recovery ,post-operative nausea and vomiting, hallucinations and Ramsey sedation
      scores of all patients will be recorded perioperatively. The Aldrete score was used to
      measure recovery from anesthesia at 5 and 10 min after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endoscopist satisfaction using 5 step scale (5= optimal condition; 1= poor condition)</measure>
    <time_frame>Immediately after procedure.</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>amount of propofol consumed during procedure</measure>
    <time_frame>Immediately after procedure.</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Sedation in ERCP</condition>
  <arm_group>
    <arm_group_label>ketamine- propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV Ketamine 1mg/kg + Propofol 1.2 mg/kg will be given for sedation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pethidine- propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.1 mg x kg(-1) pethidine + 1.2 mg x kg(-1) propofol for sedation induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine- propofol</intervention_name>
    <description>1 mg x kg(-1) ketamine + 1.2 mg x kg(-1) propofol.</description>
    <arm_group_label>ketamine- propofol</arm_group_label>
    <other_name>N01AX03 - Propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pethidine- propofol</intervention_name>
    <description>1.1 mg x kg(-1) pethidine + 1.2 mg x kg(-1) propofol for sedation induction</description>
    <arm_group_label>pethidine- propofol</arm_group_label>
    <other_name>meperidine - Propofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both gender

          -  age between 18-70

        Exclusion Criteria:

          -  pregnant patients.

          -  morbid obesity.

          -  chronic obstructive pulmonary disease.

          -  complicated airway.

          -  American society of anesthesia (ASA) physical classification IV-V.

          -  history of allergy or contraindications to the drugs used in the study

          -  emergency need for ERCP.

          -  those whose informed consent could not be signed.

          -  those with possible complex ERCP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mostafa S Abbas, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Al Rajhy liver hospital</name>
      <address>
        <city>Asyut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2015</study_first_submitted>
  <study_first_submitted_qc>January 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2016</study_first_posted>
  <last_update_submitted>April 27, 2016</last_update_submitted>
  <last_update_submitted_qc>April 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>khaled salah mohamed</investigator_full_name>
    <investigator_title>lecturer of anaesthesia and ICU</investigator_title>
  </responsible_party>
  <keyword>ketamine</keyword>
  <keyword>propofol</keyword>
  <keyword>pethidine</keyword>
  <keyword>ERCP</keyword>
  <keyword>endoscopist</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Meperidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

